CD19 and acute myeloid leukemia: These observations are consistent with the results observed in the present study, where both CD19-CAR and CD276-CAR NK-92 cells exhibit a targeted and strong cytotoxic effect against B-ALL and AML cell lines, respectively, in comparison to the parental cell lines (p < 0.0001, Figure 3).